Bonnes pratiques d'achat pour les antipaludéens à ... - libdoc.who.int
Bonnes pratiques d'achat pour les antipaludéens à ... - libdoc.who.int
Bonnes pratiques d'achat pour les antipaludéens à ... - libdoc.who.int
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
13. The <strong>int</strong>ernational pharmacopoeia, current ed. Genève, Organization mondiale de la Santé.http://apps.<strong>who</strong>.<strong>int</strong>/ph<strong>int</strong>/fr/p/about/14. Good manufacturing practices: supplementary guidelines for the manufacture of pharmaceutical excipients.In: WHO Expert Committee on Specifications for Pharmaceutical Preparations, Thirty-fifthreport. Genève, Organisation mondiale de la Santé. Série de Rapports techniques, N° 885, 1999.http://whq<strong>libdoc</strong>.<strong>who</strong>.<strong>int</strong>/trs/WHO_TRS_885.pdf15. Marketing authorization of pharmaceutical products with special reference to multisource (generic)products: a manual for drug regulatory authorities. Genève, Organisation mondiale de la Santé, 1999(Regulatory Support Series, No. 5) (WHO/DMP/RGS/98.5).http://www.<strong>who</strong>.<strong>int</strong>/prequal/info_general/documents/WHO_DMP_RGS_98_5_R.pdf16. Proposal to waive in vivo bioequivalence requirements for WHO model list of essential medicines immediate-release,solid oral dosage forms. Genève, Organisation mondiale de la Santé. Série de Rapportstechniques, N° 937 ; annexe 8, 2006.http://whq<strong>libdoc</strong>.<strong>who</strong>.<strong>int</strong>/trs/WHO_TRS_937_eng.pdf17. Incoterms. Ru<strong>les</strong> at the core of world trade. Paris, International Chamber of Commerce.http://www.iccwbo.org/incoterms/id3045/index.html18. Good manufacturing practices for pharmaceutical products: main princip<strong>les</strong>. Genève, Organisationmondiale de la Santé. Série de Rapports techniques, N° 908 ; annexe 4, 2003.http://whq<strong>libdoc</strong>.<strong>who</strong>.<strong>int</strong>/trs/WHO_TRS_908.pdf19. Procedure for prequalification of pharmaceutical products. Genève, Organisation mondiale de la Santé.Série de Rapports techniques, N° 953 ; annexe 3, 2009.http://www.<strong>who</strong>.<strong>int</strong>/medicines/publications/pharmprep/pdf_trs953.pdf#page=16420. General guidelines for the establishment, ma<strong>int</strong>enance, and distribution of chemical reference substances.Genève, Organisation mondiale de la Santé. Série de Rapports techniques, N° 943 ; annexe 3,2007.http://whq<strong>libdoc</strong>.<strong>who</strong>.<strong>int</strong>/trs/WHO_TRS_943_eng.pdf21. Stability testing conditions. Genève, Organisation mondiale de la Santé. Série de Rapports techniques,N° 937, 2006, p. 12.http://whq<strong>libdoc</strong>.<strong>who</strong>.<strong>int</strong>/trs/WHO_TRS_937_eng.pdf22. Supplementary guidelines on good manufacturing practices: validation. Genève, Organisation mondialede la Santé. Série de Rapports techniques, N° 937 ; annexe 4, 2006.http://whq<strong>libdoc</strong>.<strong>who</strong>.<strong>int</strong>/trs/WHO_TRS_937_eng.pdf23. World Malaria Report 2009. Genève, Organisation mondiale de la Santé, 2009 (ISBN 978 92 4 156390 1).(Synthèse Le Rapport 2009 sur le paludisme – disponible à l’adresse :http://www.<strong>who</strong>.<strong>int</strong>/malaria/world_malaria_report_2009/mal2009_summary_and_keypo<strong>int</strong>s_fr.pdf)24. WHO informal consultation with manufacturers of artemisinin-based pharmaceutical products in usefor the treatment of malaria, 24 August 2007. Genève, Organisation mondiale de la Santé.http://malaria.<strong>who</strong>.<strong>int</strong>/docs/diagnosisandtreatment/MtgManufacturersArtemisininDerivatives.pdf25. Affordable Medicines Facility – malaria (AMFm). Technical design. Genève, Organisation mondiale dela Santé, Partenariat Faire reculer le paludisme, 2007.http://www.rollbackmalaria.org/partnership/tf/globalsubsidy/AMFmTechProposal.pdf26. Sixteen types of counterfeit artesunate circulating in South East Asia. WHO Drug Information, 2008,22:24.http://www.<strong>who</strong>.<strong>int</strong>/medicines/publications/druginformation/issues/DrugInfo08vol22_1/en/index.html27. Guidelines for the treatment of malaria. Genève, Organisation mondiale de la Santé, 2006 (WHO/HTM/MAL/2006.1108).http://www.<strong>who</strong>.<strong>int</strong>/malaria/docs/TreatmentGuidelines2006.pdf86 <strong>Bonnes</strong> <strong>pratiques</strong> d’achat <strong>pour</strong> <strong>les</strong> antipaludéens à base d’artémisinine
Change language